Open-Label Study of Vaginal AZU-101 in Postmenopausal Women

NCT06197568 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Symptoms

Interventions

DRUG: Lasofoxifene Tartrate (AZU-101)
DRUG: Lasofoxifene Tartrate (AZU-101)
DRUG: Lasofoxifene Tartrate (AZU-101)
DRUG: Lasofoxifene Tartrate (AZU-101)
DRUG: Lasofoxifene Tartrate (AZU-101)

Sponsor

Azure Biotech Inc.